Philips Sleep Apnea Device Recall: 15M Units, Court Win

Philips has won a Dutch court ruling tied to the Philips sleep apnea device recall, in which about 15 million machines were recalled in 2021. The Enterprise Chamber of the Amsterdam Court of Appeal rejected a request from shareholders for a formal inquiry into how the company handled the problem, in a decision reported on Saturday, 10 October 2026.

The ruling ends one shareholder challenge, but it does not close the wider story. This article explains what the court decided, what shareholders alleged, what the recall has already cost, and what patients who use these machines should do.

Philips sleep apnea device recall: key points

• Who ruled: the Enterprise Chamber of the Amsterdam Court of Appeal, a Dutch court that handles corporate disputes.
• What was refused: a shareholder request for a formal inquiry into alleged misleading disclosures and management failures.
• Court’s finding: no indication that Philips knew about the problems long before it issued a warning.
• Recall size: about 15 million sleep apnea devices, recalled in 2021 over foam that could release harmful substances.
• Still open: French prosecutors are separately investigating allegations of aggravated fraud and failure to report safety risks.

What the court decided on the Philips sleep apnea device recall

A large group of shareholders asked the court to order an inquiry into Philips. They argued that executives reacted too slowly to the problems and did not give investors adequate information about the risks. Such an inquiry can be a first step towards finding mismanagement and, later, claims for damages.

The court said no. It found no indication that Philips had known about the problems long before issuing a warning, and no reason to assume that executives at its Respironics unit, which made the devices, should have stepped in earlier. Philips denied the shareholders’ accusations and said it welcomed the decision.

What the Philips sleep apnea device recall ruling does not settle

It is easy to overstate a court win. The decision, as reported, rejects a request for an inquiry. It is not a finding that the devices were safe, and it does not decide patients’ injury claims or the French criminal investigation. Our headline reading is therefore narrow: one shareholder route has been closed at this stage.

We could not confirm from the reports we reviewed whether the decision can be appealed, so we do not say either way. Reports also use different counts for the devices affected, and the total depends on how sleep devices and ventilators are counted, so “about 15 million” is best read as an approximate figure.

Why the Philips sleep apnea device recall happened

In 2021, Philips recalled continuous positive airway pressure (CPAP) machines and related devices after finding that sound-dampening foam inside could break down. The company said the foam could release particles and chemicals into the air stream that patients breathe, which raised health concerns. The recall hit Philips hard: its shares lost about two-thirds of their value when the problem emerged.

Philips has published a Philips Respironics recall information page with remediation details. According to Philips, repairs and replacements of sleep devices are nearing completion, while fixes for ventilators continue.

What the Philips sleep apnea device recall has cost so far

• 2024: Philips agreed to pay $1.1 billion to settle all personal injury claims in the US relating to the devices.
• Earlier: as publicly reported, the company also agreed to compensate users for economic loss and entered a consent decree with US regulators that limited sales of new sleep and respiratory devices in the US until conditions were met.
• France: prosecutors continue to investigate aggravated fraud and failure to report safety risks, a separate case from the Dutch ruling.

The earlier settlement and consent-decree details come from public reporting and company disclosures, and the figures can change. Check the company’s own filings for exact amounts.

What patients should do after the Philips sleep apnea device recall

The ruling does not change advice for people using affected machines. The US Food and Drug Administration (FDA) maintains recall information, and Philips has a registration and remediation process. If you use a sleep apnea device, take these steps.

• Check the model and serial number against the Philips recall lists.
• Do not stop therapy without talking to your doctor, because untreated sleep apnea carries its own risks.
• Ask your clinician or equipment supplier about a repaired or replacement device.
• Report problems or side effects to your clinician and to your national medical device regulator.

Our assessment of the Philips sleep apnea device recall

In our assessment, the Philips sleep apnea device recall will remain a case study in how device failures turn into legal and financial risk long after the safety issue itself. The Dutch court’s refusal lowers one source of pressure on Philips management, but the French inquiry and the cost of remediation still weigh on the company. Investors and patients are looking at different questions: the first at whether management failed, the second at whether their device is safe, and one ruling does not answer both.

For related device-safety and regulation coverage, see our reports on FDA clearance of an AI body-composition tool and FDA clearance for cuffless blood pressure, or browse our medical device news section.

What to watch next in the Philips sleep apnea device recall

• Whether shareholders appeal or pursue other legal routes.
• Progress of the French prosecutors’ investigation.
• Completion of remediation for sleep devices and ventilators.
• Any changes to US restrictions on new Philips sleep and respiratory device sales.

Frequently asked questions

What did the court decide about the Philips sleep apnea device recall?

It rejected shareholders’ request for a formal inquiry, finding no indication that Philips knew about the problems long before it warned.

How many devices were recalled?

About 15 million sleep apnea devices were recalled in 2021, according to reports of the ruling.

Why were the devices recalled?

Foam inside the machines could break down and release harmful substances, creating possible health risks.

Is the Philips sleep apnea device recall case over?

No. French prosecutors are still investigating, and the decision concerns only the request for an inquiry.

Should I stop using my CPAP machine?

Do not stop without medical advice. Talk to your doctor about your device and check the recall information.

How we reported this: we relied on reports of the Dutch court ruling published on 10 October 2026, and on Philips and regulator recall information. Some background figures come from public reporting and are labelled as such. Last updated: 11 October 2026. This article is news reporting and not medical, legal or investment advice.